Overview

Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America

Status:
Withdrawn

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

This is a multicenter, prospective, randomized, double-blind, triple-dummy, parallel group, comparative, study designed to evaluate the efficacy of Ibuprofen (IBU) 200 mg/ Phenylephrine (PE) 10 mg and IBU 200 mg/ PE 10 mg/ Chlorpheniramine (CHLOR) 4 mg on the relief of symptoms of the common cold and flu. The reference product that the active treatments will be compared to is paracetamol (PARA) 500 mg.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Acetaminophen
Ibuprofen
Oxymetazoline
Phenylephrine